Staphylococcal Enterotoxin-Specific IgE Sensitization: A Potential Predictor of Fixed Airflow Obstruction in Elderly Asthma

Purpose Staphylococcus aureus enterotoxin-specific immunoglobulin E (SE-sIgE) sensitization tends to increase with age and is known to be associated with asthma and severity in older adults. However, the long-term impact of SE-sIgE in the elderly remains unknown. This study aimed to examine the relationships between SE-sIgE and fixed airflow obstruction (FAO) in a cohort of elderly asthmatics. Methods A total of 223 elderly asthmatics and 89 controls were analyzed. Patients were assessed for demographics, history of chronic rhinosinusitis (CRS), asthma duration, acute exacerbation frequency, and lung function at baseline and then were prospectively followed up for 2 years. Serum total IgE and SE-sIgE levels were measured at baseline. Airflow obstruction was defined as forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio < 0.7 at baseline and FAO was defined as FEV1/FVC ratio < 0.7 over the 2-year follow-up. Results At baseline, the prevalence of airflow obstruction was 29.1%. Patients with airflow obstruction were significantly more likely to be male, and have a positive smoking history, comorbid CRS, and higher levels of SE-sIgE than those without airflow obstruction. Multivariate logistic regression analysis showed that airflow obstruction was significantly associated with current smoking and SE-sIgE sensitization at baseline. After the 2-year follow-up, baseline SE-sIgE sensitization was consistently related to FAO. Meanwhile, the number of exacerbations per year was significantly correlated with SE-sIgE levels. Conclusions Baseline SE-sIgE sensitization was significantly associated with the number of asthma exacerbations and FAO after the 2-year follow-up in elderly asthmatics. These findings warrant further investigation of the direct and mediating roles of SE-sIgE sensitization on airway remodeling.

[1]  T. Cross,et al.  Fixed Airflow Obstruction in Asthma: A Problem of the Whole Lung Not of Just the Airways , 2022, Frontiers in Physiology.

[2]  D. Wang,et al.  European Position Paper on Rhinosinusitis and Nasal Polyps 2020. , 2020, Rhinology.

[3]  C. Bachert,et al.  Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge , 2020, European Respiratory Journal.

[4]  F. Perrotta,et al.  Staphylococcus Aureus in chronic airway diseases: An overview. , 2019, Respiratory medicine.

[5]  J. Bousquet,et al.  Sensitisation to staphylococcal enterotoxins and asthma severity: a longitudinal study in the EGEA cohort , 2019, European Respiratory Journal.

[6]  H. Hammad,et al.  Protein crystallization promotes type 2 immunity and is reversible by antibody treatment , 2019, Science.

[7]  C. Bachert,et al.  Staphylococcus aureus Nasal Colonization and Asthma in Adults: Systematic Review and Meta-Analysis. , 2019, The journal of allergy and clinical immunology. In practice.

[8]  P. Busse,et al.  Asthma in the elderly and late‐onset adult asthma , 2018, Allergy.

[9]  Yoshihiro Kanemitsu,et al.  Sensitization to Staphylococcus aureus enterotoxins in smokers with asthma. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[10]  C. Weidenmaier,et al.  The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota , 2017, Nature Reviews Microbiology.

[11]  C. Bachert,et al.  Staphylococcal enterotoxin IgE sensitization in late‐onset severe eosinophilic asthma in the elderly , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  N. Scichilone,et al.  Asthma in the elderly: a different disease? , 2016, Breathe.

[13]  K. Hirai,et al.  Association between specific IgE to Staphylococcus aureus enterotoxins A and B and asthma control. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  Sang-Heon Cho,et al.  Challenges in the Management of Asthma in the Elderly , 2015, Allergy, asthma & immunology research.

[15]  C. Bachert,et al.  Staphylococcal enterotoxin sensitization in a community‐based population: a potential role in adult‐onset asthma , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  D. Jarvis,et al.  Staphylococcus aureus enterotoxin‐specific IgE is associated with asthma in the general population: a GA2LEN study , 2013, Allergy.

[17]  Sang-Heon Cho,et al.  Prediction of Asthma Exacerbations in Elderly Adults: Results of a 1‐Year Prospective Study , 2013, Journal of the American Geriatrics Society.

[18]  Sang-Heon Cho,et al.  Staphylococcal enterotoxin specific IgE and asthma: a systematic review and meta-analysis , 2013, Asia Pacific allergy.

[19]  K. Van Steen,et al.  Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. , 2012, The Journal of allergy and clinical immunology.

[20]  C. Bachert,et al.  Exacerbation of cigarette smoke-induced pulmonary inflammation by Staphylococcus aureus Enterotoxin B in mice , 2011, Respiratory research.

[21]  P. Howarth,et al.  Staphylococci and staphylococcal superantigens in asthma and rhinitis: a systematic review and meta‐analysis , 2011, Allergy.

[22]  C. Bachert,et al.  Mucosal tissue polyclonal IgE is functional in response to allergen and SEB , 2011, Allergy.

[23]  C. Bachert,et al.  Staphylococcus aureus and Chronic Airway Disease , 2010, The World Allergy Organization journal.

[24]  S. Guerra,et al.  Epidemiology of the origins of airflow limitation in asthma. , 2009, Proceedings of the American Thoracic Society.

[25]  N. Thomson,et al.  Asthma in smokers: challenges and opportunities , 2009, Current opinion in pulmonary medicine.

[26]  S. Wenzel,et al.  Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. , 2007, Chest.

[27]  A. James,et al.  Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. , 2005, American journal of respiratory and critical care medicine.

[28]  C. Bachert,et al.  Increased IgE-antibodies to Staphylococcus aureus enterotoxins in patients with COPD. , 2004, Respiratory medicine.

[29]  C. Bachert,et al.  Staphylococcus aureus enterotoxins: a key in airway disease? , 2002, Allergy.

[30]  B. Wedi,et al.  Staphylococcal exotoxins exert proinflammatory effects through inhibition of eosinophil apoptosis, increased surface antigen expression (CD11b, CD45, CD54, and CD69), and enhanced cytokine-activated oxidative burst, thereby triggering allergic inflammatory reactions. , 2002, The Journal of allergy and clinical immunology.

[31]  D. Johns,et al.  Reduced airway distensibility, fixed airflow limitation, and airway wall remodeling in asthma. , 2001, American journal of respiratory and critical care medicine.

[32]  E. Miller,et al.  Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin A (SEA) , 1996, Inflammation Research.

[33]  H. Sampson,et al.  Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. , 1993, The Journal of clinical investigation.

[34]  J. Morris.  Spirometry in the evaluation of pulmonary function. , 1976, The Western journal of medicine.

[35]  C. Bachert,et al.  Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. , 2008, The Journal of allergy and clinical immunology.

[36]  J. Hankinson,et al.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. , 2000, American journal of respiratory and critical care medicine.